MaRS Discovery District owns and operates a convergence center. The company offers business research, information technology; pharmaceutical; and optical sciences advisory, and start up business assistance services. Additionally, it provides risk capital management services, strategic business solutions, and global markets access to businesses. MaRS Discovery District was founded in 2000 and is based in Toronto, Canada.
101 College Street
Toronto, ON M5G 1L7
Founded in 2000
Manulife and MaRS Discovery District Announce Partnership
Nov 23 15
Manulife has partnered with MaRS Discovery District, continuing to transform how it connects with customers worldwide by collaborating with innovators and startups on forward-thinking solutions. Manulife will be a part of MaRS' FinTech Cluster, and will join companies like Airbnb, Facebook Canada, Moneris, PayPal and other startups at the centre. As part of the new partnership, MaRS will become Manulife's Toronto location for its Lab of Forward Thinking (LOFT). Centered on innovation, the tangible LOFT spaces provide a platform for employees across the company to collaborate and devise new technological solutions for Manulife's various wealth and asset management, and insurance business lines.
MaRS Discovery District and McCarthy Tétrault Announces Partnership Focused on Legal Innovation
Nov 3 15
MaRS Discovery District and McCarthy Tétrault announced the launch of a partnership dedicated to legal innovation. The partnership will enable promising companies from MaRS' LegalX cluster to pilot their technologies by working with McCarthy Tétrault lawyers across Canada. It will also allow McCarthy Tétrault to further develop its innovative and market-leading legal solutions with MaRS in order to deliver better outcomes for its clients. The partnership will further leverage existing initiatives such as MaRS LegalX's LegalLean series and entrepreneurship programs.
The Ontario Government, University of Toronto, and MaRS Discovery District Announce Collaboration with Janssen to Launch Johnson & Johnson Innovation, JLABS Incubator Model in Toronto
Sep 8 15
The Ontario Government, University of Toronto, and MaRS Discovery District (MaRS) announced a collaboration with Janssen Inc. to launch the successful Johnson & Johnson Innovation, JLABS incubator model in Toronto. The new facility, called JLABS @ Toronto, will open in spring of 2016 at MaRS Discovery District and will support start-ups with lab space, programs, and potential investment partners as they work to build important, successful early-stage companies. As the first JLABS to open outside the United States, JLABS at Toronto joins a network of life science facilities that are based throughout the United States in San Diego, San Francisco, South San Francisco, Boston and Houston. These facilities are home to over 100 early-stage companies advancing bio/pharmaceutical, medical device, consumer and digital health programs. JLABS at Toronto will be located at MaRS Discovery District, occupying one floor of the West Tower. JLABS at Toronto will provide startups with many of the advantages of being part of an established innovation centre - such as access to talent and mentors, large existing firms and research universities, capital and convergence opportunities with other sectors. When complete, the 40,000-square foot facility will include cutting-edge, modular and scalable lab space, equipment, with access to scientific, industry and capital funding experts. JLABS at Toronto is a collaboration among Johnson & Johnson Innovation, The University of Toronto, MaRS Discovery District, Janssen Inc., MaRS Innovation, and the Government of Ontario. Hospital participants include: Centre for Addiction and Mental Health, The Hospital for Sick Children (SickKids), Sinai Health System, St. Michael's Hospital, Sunnybrook Health Sciences Centre, and University Health Network. Construction of JLABS at Toronto will begin in 2015, and is expected to be ready for occupancy by spring 2016. Over the coming months, best practices pioneered at other JLABS will be adopted to accelerate the impact and success of this new collaboration.